好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Quantification of Neuronal Loss in Multiple Sclerosis: A PET Study with [11C]-Flumazenil
MS and Related Diseases
(-)
056
Authors/Disclosures
Bruno Stankoff, MD, PhD (Hopital De La Pitie Salpetriere) The institution of Bruno Stankoff, MD, PhD has received research support from Roche, Sanofi, Serono . The institution of Bruno Stankoff, MD, PhD has received research support from Novartis.
No disclosure on file
No disclosure on file
No disclosure on file
Rana Assouad, MD No disclosure on file
No disclosure on file
Ayman P. Tourbah (Department of Neurology University Hospital Raymond Poincaré) No disclosure on file
No disclosure on file
No disclosure on file
Marie-Laure Welter (Hopital Charles Nicolle) No disclosure on file
Catherine Lubetzki (Hopital De La Salpetriere) Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK SERONO. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REWIND.
No disclosure on file
No disclosure on file
No disclosure on file
Michel Bottlaender (Centre Hospitalier Frederic Joliot) Michel Bottlaender has nothing to disclose.